Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin

Neurology

Volumn 78, Issue 16, 2012, Pages 1245-1249

  McDade, E ^a   Boeve, B F ^a   Burrus, T M ^a   Boot, B P ^a   Kantarci, K ^a   Fields, J ^a   Lowe, V J ^a   Peller, P ^a   Knopman, D ^a   Baker, M ^b   Finch, N ^b   Rademakers, R ^b   Petersen, R ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN;

ADULT; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; EXECUTIVE FUNCTION; EXON; FRONTOTEMPORAL DEMENTIA; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; LANGUAGE DISABILITY; LEFT HEMISPHERE; MALE; MEMORY DISORDER; MONOZYGOTIC TWINS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PGRN GENE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84860719745     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318251594c     Document Type: Article

References (10)

1. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442: 916-919. (Pubitemid 44285946)
2. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442: 920-924. (Pubitemid 44285947)
3. Boeve BF, Maraganore DM, Parisi JE, et al. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology. Dement Geriatr Cogn Disord 2002;13:80-90. (Pubitemid 34161152)
4. Gliebus G, Bigio EH, Gasho K, et al. Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation. Neurology 2010;74:1607-1610.
5. Kelley BJ, Haidar W, Boeve BF, et al. Prominent phenotypic variability associated with mutations in progranulin. Neurobiol Aging 2009;30:739-751.
6. Yu CE, Bird TD, Bekris LM, et al. The spectrum of mutations in progranulin: A collaborative study screening 545 cases of neurodegeneration. Arch Neurol 2010;67:161-170.
7. Le Ber I, Camuzat A, Hannequin D, et al. Phenotype variability in progranulin mutation carriers: A clinical, neuropsychological, imaging and genetic study. Brain 2008;131: 732-746. (Pubitemid 351294727)
8. Finch N, Carrasquillo MM, Baker M, et al. TMEM106B regulates progranulin levels and penetrance of FTLD in GRN mutation carriers. Neurology 2011;76:467-474.
9. Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248.
10. Mesulam M, Johnson N, Krefft TA, et al. Progranulin mutations in primary progressive aphasia: The PPA1 and PPA3 families. Arch Neurol 2007;64:43-47. (Pubitemid 46072422)